These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 9071199

  • 1. A comparison between aspirin and pentoxifylline in relieving claudication due to peripheral vascular disease in the elderly.
    Ciocon JO, Galindo-Ciocon D, Galindo DJ.
    Angiology; 1997 Mar; 48(3):237-40. PubMed ID: 9071199
    [Abstract] [Full Text] [Related]

  • 2. A randomized trial of iloprost in patients with intermittent claudication.
    Creager MA, Pande RL, Hiatt WR.
    Vasc Med; 2008 Feb; 13(1):5-13. PubMed ID: 18372433
    [Abstract] [Full Text] [Related]

  • 3. Pentoxifylline for intermittent claudication.
    Salhiyyah K, Forster R, Senanayake E, Abdel-Hadi M, Booth A, Michaels JA.
    Cochrane Database Syst Rev; 2015 Sep 29; 9(9):CD005262. PubMed ID: 26417854
    [Abstract] [Full Text] [Related]

  • 4. Failure of pentoxifylline or cilostazol to improve blood and plasma viscosity, fibrinogen, and erythrocyte deformability in claudication.
    Dawson DL, Zheng Q, Worthy SA, Charles B, Bradley DV.
    Angiology; 2002 Sep 29; 53(5):509-20. PubMed ID: 12365857
    [Abstract] [Full Text] [Related]

  • 5. Pentoxifylline for intermittent claudication.
    Salhiyyah K, Senanayake E, Abdel-Hadi M, Booth A, Michaels JA.
    Cochrane Database Syst Rev; 2012 Jan 18; 1():CD005262. PubMed ID: 22258961
    [Abstract] [Full Text] [Related]

  • 6. Effects of indobufen and pentoxifylline on walking capacity and hemostasis in patients with intermittent claudication: results of six months of treatment.
    Panchenko E, Eshkeeva A, Dobrovolsky A, Titaeva E, Podinovskaya Ya, Hussain KM, Karpov Yu.
    Angiology; 1997 Mar 18; 48(3):247-54. PubMed ID: 9071201
    [Abstract] [Full Text] [Related]

  • 7. Improving walking ability and ankle brachial pressure indices in symptomatic peripheral vascular disease with intermittent pneumatic foot compression: a prospective controlled study with one-year follow-up.
    Delis KT, Nicolaides AN, Wolfe JH, Stansby G.
    J Vasc Surg; 2000 Apr 18; 31(4):650-61. PubMed ID: 10753272
    [Abstract] [Full Text] [Related]

  • 8. Comparative effects of cilostazol and other therapies for intermittent claudication.
    Dawson DL.
    Am J Cardiol; 2001 Jun 28; 87(12A):19D-27D. PubMed ID: 11434896
    [Abstract] [Full Text] [Related]

  • 9. Management of intermittent claudication with pentoxifylline: meta-analysis of randomized controlled trials.
    Hood SC, Moher D, Barber GG.
    CMAJ; 1996 Oct 15; 155(8):1053-9. PubMed ID: 8873633
    [Abstract] [Full Text] [Related]

  • 10. Systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication.
    Stevens JW, Simpson E, Harnan S, Squires H, Meng Y, Thomas S, Michaels J, Stansby G.
    Br J Surg; 2012 Dec 15; 99(12):1630-8. PubMed ID: 23034699
    [Abstract] [Full Text] [Related]

  • 11. Differential effects of cilostazol and pentoxifylline on vascular endothelial growth factor in patients with intermittent claudication.
    Lee TM, Su SF, Tsai CH, Lee YT, Wang SS.
    Clin Sci (Lond); 2001 Sep 15; 101(3):305-11. PubMed ID: 11524048
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cost effectiveness of cilostazol compared with naftidrofuryl and pentoxifylline in the treatment of intermittent claudication in the UK.
    Guest JF, Davie AM, Clegg JP.
    Curr Med Res Opin; 2005 Jun 15; 21(6):817-26. PubMed ID: 15969881
    [Abstract] [Full Text] [Related]

  • 14. Effects of cilostazol and pentoxifylline on forearm reactive hyperemia response, lipid profile, oxidative stress, and inflammatory markers in patients with intermittent claudication.
    de Albuquerque RM, Virgini-Magalhães CE, Lencastre Sicuro F, Bottino DA, Bouskela E.
    Angiology; 2008 Jun 15; 59(5):549-58. PubMed ID: 18388031
    [Abstract] [Full Text] [Related]

  • 15. The effect of withdrawal of drugs treating intermittent claudication.
    Dawson DL, DeMaioribus CA, Hagino RT, Light JT, Bradley DV, Britt KE, Charles BE.
    Am J Surg; 1999 Aug 15; 178(2):141-6. PubMed ID: 10487267
    [Abstract] [Full Text] [Related]

  • 16. A comparison of cilostazol and pentoxifylline for treating intermittent claudication.
    Dawson DL, Cutler BS, Hiatt WR, Hobson RW, Martin JD, Bortey EB, Forbes WP, Strandness DE.
    Am J Med; 2000 Nov 15; 109(7):523-30. PubMed ID: 11063952
    [Abstract] [Full Text] [Related]

  • 17. Treatment of intermittent claudication with pentoxifylline and cilostazol.
    Tjon JA, Riemann LE.
    Am J Health Syst Pharm; 2001 Mar 15; 58(6):485-93; quiz 494-6. PubMed ID: 11286146
    [Abstract] [Full Text] [Related]

  • 18. Pentoxifylline in the nonoperative management of intermittent claudication.
    Kokesh J, Kazmers A, Zierler RE.
    Ann Vasc Surg; 1991 Jan 15; 5(1):66-70. PubMed ID: 1997079
    [Abstract] [Full Text] [Related]

  • 19. [Prostacyclin and pentoxifylline in the treatment of patients with inoperable occlusions of the peripheral arteries of the lower extremities].
    Maksimović ZV.
    Srp Arh Celok Lek; 1999 Jan 15; 127(7-8):249-53. PubMed ID: 10624398
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.